THURSDAY, SEPTEMBER 21, 2017

Shanghai calls for blood in swine-flu war

SHANGHAI Read More »

Medical countermeasure development should be priority, BARDA director says

WASHINGTON Read More »

Union takes hospital to arbitration over workers' refusal to get vaccination

PHILADELPHIA Read More »

NanoBio says vaccine adjuvant also effective by injection

ANN ARBOR, Mich. Read More »

Web system will track outbreaks of disease

ABU DHABI, United Arab Emirates Read More »

Study confirms low mortality for H1N1 flu, but CDC director says threat isn't over

WASHINGTON Read More »

Developing nations' vaccine shortage may threaten security, former WHO official says

Flu vaccine shortages in developing nations may destabilize global security should the H1N1 virus become more deadly, said David Heymann, a former deputy head of the World Health Organization. Read More »

Skepticism on H1N1 flu's danger limits European vaccine demand

Fewer Europeans are getting pandemic flu vaccine than typically get seasonal flu shots, as safety concerns and lower-than-expected death rates have damped demand, Bloomberg reported Dec. 8. Read More »

Geron says interim data shows cancer vaccine meets goals

MENLO PARK, Calif. Read More »

Stanford fellow argues for better vaccines for the next pandemic

The H1N1 swine flu has sickened at least 22 million and killed almost 4,000 in the United States since April, according to the Centers for Disease Control and Prevention. Read More »

N.Y. autopsies show 2009 H1N1 influenza virus damages entire airway

In fatal cases of 2009 H1N1 influenza, the virus can damage cells throughout the respiratory airway, much like the viruses that caused the 1918 and 1957 influenza pandemics. Read More »

Flu pandemics could affect blood supplies, German study says

A German research team has discovered that a severe pandemic scenario could quickly lead to a deficit of up to 96,000 red blood cell (RBC) transfusion units in Germany alone, creating potentially fatal outcomes. Read More »

Dynavax gets go-ahead to produce of hepatitis B vaccine component

Dynavax Technologies Corp. announced Dec. 9 that its manufacturing facility in Dusseldorf, Germany, has been approved for the commercial production of hepatitis B surface antigen. Read More »

Sanofi Pasteur expands global dengue vaccine clinical program in Latin America

MEXICO CITY Read More »

North Korea accepts South Korea's offer of H1N1 flu medication

SEOUL, South Korea Read More »

NIAID trial of 2009 H1N1 influenza vaccine enrolling HIV-positive adults

HIV-infected adults are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine, the National Institutes of Health announced Dec. 10. Read More »

Health experts say more funds needed for TB tests, drugs, vaccines

CANCUN, Mexico Read More »

Human trial for spoon-fed vaccines to begin

Human trials are soon to begin on an Australian-pioneered technique that could revolutionize the way we vaccinate Read More »

China worries swine flu vaccine campaign faltering

BEIJING (Reuters) - China's vaccination campaign against the H1N1 flu strain is not proceeding as fast as it should be partly because people are needlessly worried about the vaccine Read More »

NIAID testing candidate DNA vaccine for 2009 H1N1 influenza

WASHINGTON Read More »